Clinical Trials Logo

Psychotropic Induced Weight Gain clinical trials

View clinical trials related to Psychotropic Induced Weight Gain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01231074 Completed - Obesity Clinical Trials

Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

GFMS
Start date: February 2010
Phase: Phase 1
Study type: Interventional

Recent but limited short term studies have shown that Metformin can slow down weight gain in obese children and in children with psychotropic-induced weight gain, two distinct pediatric populations that are at risk for obesity related co-morbid conditions. The purpose of this study is to conduct a long term prospective pilot cohort study to investigate the use of Metformin to prevent or decrease weight gain in two cohorts of children: 1) children with psychotropic induced weight gain on Metformin and 2) children with BMI above the 95th percentile on Metformin. Both study populations will be enrolled in a lifestyle weight management program